MSH2
MSH2 (mutS homolog 2) is a nuclear component of the post-replicative DNA mismatch repair system. It partners with MSH6 or MSH3 to recognise mismatches in DNA, and is also known as HNPCC, HNPCC1, MSH-2 and COCA1. Browse Assay Genie's current range of MSH2 research reagents below, or read on for the biology behind the target.
MSH2 is a component of the post-replicative DNA mismatch repair (MMR) system. It forms two heterodimers: MutS alpha (MSH2-MSH6) and MutS beta (MSH2-MSH3). Both bind DNA mismatches and initiate repair. When bound, the heterodimers bend the DNA helix and shield approximately 20 base pairs. MutS alpha recognises single base mismatches and dinucleotide insertion-deletion loops, while MutS beta recognises larger loops of up to 13 nucleotides.
After mismatch binding, MutS alpha or MutS beta forms a ternary complex with the MutL alpha heterodimer. This complex is thought to direct the downstream steps of repair, including strand discrimination, excision and resynthesis. MSH2 also recruits the DNA helicase MCM9 to chromatin, which unwinds the mismatch-containing strand. ATP binding and hydrolysis are central to this process. Mismatched DNA provokes ADP-to-ATP exchange in MutS alpha, and the resulting conformational change converts it into a sliding clamp that diffuses along the DNA backbone. MutS alpha may also contribute to homologous recombination repair, and in melanocytes it may modulate UV-B-induced cell cycle regulation and apoptosis.
The MSH2 gene encodes a protein of the DNA mismatch repair MutS family, found in the nucleus and on chromosomes. HGNC places it among the MutS homologs and the BRCA1-associated genome surveillance complex. When cloned, it proved to be a human homologue of the E. coli mismatch repair gene mutS, hence its earlier names referring to colon cancer, nonpolyposis type 1. The locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC), consistent with the microsatellite alterations (RER+ phenotype) seen in that disease. Two transcript variants encoding different isoforms have been reported. Mouse and rat orthologs are both named Msh2.
MSH2 forms MutS alpha and MutS beta, which bind mismatches and loops and initiate repair, making it central to studies of MMR.
The MSH2 locus is frequently mutated in hereditary nonpolyposis colon cancer, linking the gene to microsatellite alterations and the RER+ phenotype.
MutS alpha may contribute to homologous recombination repair, and MSH2 belongs to the BRCA1-associated genome surveillance complex.
In melanocytes, MSH2 may modulate UV-B-induced cell cycle regulation and apoptosis, offering a route to study DNA damage responses.
MSH2 is part of the post-replicative DNA mismatch repair system. It pairs with MSH6 to form MutS alpha or with MSH3 to form MutS beta, which bind mismatches and loops in DNA and then engage MutL alpha to direct strand discrimination, excision and resynthesis.
MSH2 is also called HNPCC, HNPCC1, MSH-2 and COCA1. Earlier names include mutS (E. coli) homolog 2 (colon cancer, nonpolyposis type 1). UniProt lists the protein as DNA mismatch repair protein Msh2, and two transcript variants encoding different isoforms are known.
The MSH2 locus is frequently mutated in hereditary nonpolyposis colon cancer. The gene is a human homologue of E. coli mutS, and mouse and rat orthologs are both named Msh2. Check the datasheet of any product for its validated reactivity.
MSH6, the MutS alpha partner of MSH2, and other mismatch repair targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P43246; product specifications from Assay Genie datasheets.